RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Regulation and Role of EZH2 in Cancer

        Hirohito Yamaguchi,Mien-Chie Hung 대한암학회 2014 Cancer Research and Treatment Vol.46 No.3

        Polycomb repressive complex 2 (PRC2) is the epigenetic regulator that induces histone H3lysine 27 methylation (H3K27me3) and silences specific gene transcription. Enhancer ofzeste homolog 2 (EZH2) is an enzymatic subunit of PRC2, and evidence shows that EZH2plays an essential role in cancer initiation, development, progression, metastasis, and drugresistance. EZH2 expression is indeed regulated by various oncogenic transcription factors,tumor suppressor miRNAs, and cancer-associated non-coding RNA. EZH2 activity is alsocontrolled by post-translational modifications, which are deregulated in cancer. The canonicalrole of EZH2 is gene silencing through H3K27me3, but accumulating evidence showsthat EZH2 methlyates substrates other than histone and has methylase-independentfunctions. These non-canonical functions of EZH2 are shown to play a role in cancerprogression. In this review, we summarize current information on the regulation and rolesof EZH2 in cancer. We also discuss various therapeutic approaches to targeting EZH2.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼